Moses Lake Pharmacy Recalls Chorionic Gonadotropin Due to Sterility Concerns
JD & SN Inc. is recalling specific vials of Chorionic Gonadotropin because the FDA cannot assure the sterility of the compounded drug.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text identifies the recall as FDA Class II. According to the severity rubric, an FDA Class II recall with potential for adverse health consequences (lack of sterility assurance) corresponds to a score of 4 (Severe), as it is not Class I but involves a significant risk factor.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling specific vials of Chorionic Gonadotropin, Injectable Solution. The recall involves 44 vials of various sizes, including 4 mL, 5 mL, 6 mL, 7.5 mL, 9 mL, 10 mL, 12 mL, 15 mL, 20 mL, and 28 mL containers. The product is prescription-only and was distributed nationwide.
The recall was initiated due to a lack of assurance of sterility. The FDA has determined that it cannot guarantee that all sterile human compounded drugs within their expiration dates are sterile. This classification is designated as FDA Class II, which indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Patients who have received this medication should contact their healthcare provider for further instructions. The recall is limited to the specific lot codes and quantities listed in the official FDA notice. Consumers should not use the remaining vials until they have consulted with a medical professional.
The recalled product
- Product
- CHORIONIC GONADOTROPIN, Injectable Solution, 200 UNITS/0.1 ML, vial sizes: 4 mL; 5 mL; 6 mL; 7.5 mL ; 9 mL, 10 mL; 12 mL; 15 mL; 20 mL; 28 mL; Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 11032014@10
- 12082014@3
- t01082015@26
- t03092015@26
- t03132015@13
- t03162015@12
- t03242015@19
- t04092015@21
- t05132015@28
- t05132015@44
- t05202015@22
- t05262015@14
- t05272015@36
- t06172015@27
- t06182015@7
- t06242015@9
- t06292015@11
- t07092015@42
- t07102015@25
- t08012014@1
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29